BlackRock, Inc. 13D and 13G filings for Blueprint Medicines Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-24 09:46 am Purchase |
2023-12-31 | 13G | Blueprint Medicines Corporation BPMC |
BlackRock Inc. BLK |
6,584,176 10.800% |
309,654 (+4.94%) |
Filing |
| 2023-01-26 08:52 am Unchanged |
2022-12-31 | 13G | Blueprint Medicines Corporation BPMC |
BlackRock Inc. BLK |
6,274,522 10.500% |
0 (Unchanged) |
Filing |
| 2023-01-20 09:43 am Purchase |
2022-12-31 | 13G | Blueprint Medicines Corporation BPMC |
BlackRock Inc. BLK |
6,274,522 10.500% |
281,919 (+4.70%) |
Filing |
| 2022-11-09 3:21 pm Purchase |
2022-10-31 | 13G | Blueprint Medicines Corporation BPMC |
BlackRock Inc. BLK |
5,992,603 10.000% |
655,729 (+12.29%) |
Filing |
| 2022-02-03 4:41 pm Purchase |
2021-12-31 | 13G | Blueprint Medicines Corporation BPMC |
BlackRock Inc. BLK |
5,336,874 9.100% |
280,711 (+5.55%) |
Filing |
| 2021-01-28 5:56 pm Purchase |
2020-12-31 | 13G | Blueprint Medicines Corporation BPMC |
BlackRock Inc. BLK |
5,056,163 9.100% |
799,043 (+18.77%) |
Filing |